Doctor’s Allegation Of Drug Safety Problem Starts Controversy With Manufacturer
In Brief: Calabresi Named To President’s Cancer Panel; Mays Leaves NCI Technology Office For IVAX
Breast Cancer Coalition Widens Its Agenda For Advocacy, Vows To Fight NIH Cutbacks
NCI’s Goal To Increase Minority Participation In Trials, Sondik Says
UT Southwestern, M.D. Anderson Form Cancer Center In Dallas
NCI Scientists Immunize A Healthy BMT Donor Against Myeloma
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Cancer hospitals brace for impact, as CMS moves to slash 340B payments by 33%
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Susan Wojcicki Foundation pushes for rethinking of strategies for early lung cancer detection
- Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Hegseth offers soldiers testosterone and FDA loosens safety warnings. Is the science there?









